高级检索
当前位置: 首页 > 详情页

Polygonum multiflorum Stilbene Glycoside Oligomers induce the ferroptosis of triple negative breast cancer cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ, Sch Clin Med, Baoding 071000, Peoples R China [2]Hebei Univ, Affiliated Hosp, Dept Breast Surg, Baoding 071000, Peoples R China [3]Hebei Univ, Affiliated Hosp, Dept Med Oncol, Hebei Key Lab Canc Radiotherapy & Chemotherapy, Baoding 071000, Peoples R China [4]Hebei Univ, Affiliated Hosp, Dept Clin Lab, Baoding 071000, Peoples R China [5]Hebei Univ, Sch Basic Med Sci, Dept Histol & Embryol, Baoding 071000, Peoples R China [6]Shenyang Med Coll, Sch Tradit Chinese Med, Shenyang 110034, Peoples R China
出处:
ISSN:

关键词: Polygonum multiflorum Thunb Trans 2 3 5 4 & backprime -tetrahydroxystilbene 2-O-beta-D glucopyranoside Triple negative breast cancer

摘要:
The quality control testing component and main active ingredient of Polygonum multiflorum Thunb. (P. multiflorum), known as trans-2,3,5,4 & backprime;-tetrahydroxystilbene 2-O-beta-D-glucopyranoside (TSG), exhibits diverse biological activities. In this study, we report, for the first time, the potent ability of TSG to induce ferroptosis in triple negative breast cancer (TNBC) cell lines and to inhibit the proliferation of TNBC cells. Treatment with TSG triggers the production of lipid peroxides, 4-hydroxynonenal (4-HNE), and reactive oxygen species (ROS) in TNBC cells, indicating the induction of ferroptosis. Both in vivo and in vitro experiments confirmed the inhibitory effects of TSG on TNBC cell proliferation and metastasis. Furthermore, we investigated the effects of other stilbene glycoside oligomers, alongside TSG, on TNBC cell lines. These compounds also demonstrated the ability to induce ferroptosis and suppress TNBC cells' proliferation and metastasis. These findings suggest that the induction of ferroptosis by TSG and related compounds could potentially serve as a promising therapeutic strategy for TNBC treatment.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2026]版:
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2025]版:
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2025版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Hebei Univ, Sch Clin Med, Baoding 071000, Peoples R China [2]Hebei Univ, Affiliated Hosp, Dept Breast Surg, Baoding 071000, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号